HOME >> BIOLOGY >> NEWS
Outwitting pesky parasites

MADISON, WI, July 15, 2007 - Across the southern United States, an invisible, yet deadly parasite known as the root-knot nematode is crippling soybean crops. While plant breeders are racing to develop cultivars resistant to the root-knot nematode, they are being slowed down by current time-consuming and expensive methods of screening for resistant plants. Now, researchers believe they have found a shortcut for screening resistant soybean crops.

Researchers at the University of Georgia report the discovery of several molecular markers that will help soybean breeders to accurately screen for root-knot resistant plants at a fraction of the time and cost of current screening techniques in the July issue of The Plant Genome.

While previous studies of soybean crops helped researchers to locate genes associated with root-knot nematode resistance, University of Georgia scientists recently identified single nucleotide polymorphisms (SNPs), slight variations in the DNA, nearby genetic regions that code root-knot nematode resistance. After linking the identified SNPs to root-knot nematode resistance, scientists developed a marker assisted screening test that used SNPs to determine whether or not plants were resistant to root-knot nematode.

The basic objective of any breeding scheme is to identify elite individuals that can pass on their desirable characteristics, explained Bo-Keun Ha, lead author of study. While Ha says most conventional breeders rely on phenotypic evaluations of plants to select the plant with most desirable traits, this process takes time and money. For example, if a breeder wants to select plants with resistance to root-knot nematode based upon a phenotypic evaluation alone, he or she must grow a large population of plants, inoculate plants with nematode eggs, wait until the growth of the nematode and evaluate the damage before selecting the most resistant plants.

Instead of relying on the time-consuming phenotyp
'"/>

Contact: Sara Uttech
suttech@crops.org
608-268-4948
Crop Science Society of America
15-Jul-2007


Page: 1 2

Related biology news :

1. A researcher identifies the parasites responsible for Chagas and Leishmaniasis epidemics
2. Bacterial protein shows promise in treating intestinal parasites
3. Study shows that parasites form the thread of food webs
4. How healthy is that marsh? Biologists count parasites
5. Malaria parasites develop in lymph nodes
6. MBL study shows how good cholesterol (HDLs) provide human immunity to certain parasites
7. Measuring hidden parasites in falciparum malaria
8. Researchers at UGA provide first look at protein expression in Chagas disease-causing parasites
9. Genome sequences for three deadly parasites provide foundation for new drugs
10. Deadly parasites show common genetic core
11. Tracking a killer: Observing liver invasion by malarial parasites

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Outwitting pesky parasites

(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/12/2015)... 12, 2015   MedNet Solutions , a ... study management systems, has recently bolstered its ... iMedNet as the eClinical ... and healthcare consultants.  Building on the Program,s existing ... and numerous co-marketing opportunities), MedNet,s new and improved ...
(Date:2/9/2015)... Feb. 9, 2015  Lintec of America recently announced ... carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, ... Leveraging the vast industrial resources of the ... , Lintec of America is forming the Nano-Science ... , focusing on scaling up the manufacturing and ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
(Date:3/4/2015)... , March 4, 2015  BioClinica®, Inc., ... technology provider, today announced that clinical trial ... convened at its annual European User Conference ... to discuss the use of its eClinical ... eClinical technologies include: the Microsoft Office-Smart OnPoint ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... (PCR) represents one of the fastest growing technologies in ... biologists in subcellular visualization is driving growth in nucleic ... for deeper understanding of gene expressions will continue to ... Expanding applications in fields ranging from pharma, biotech, food ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
(Date:3/3/2015)... March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... and molecular diagnostics that target the underlying mechanisms of ... seventh-month period ended December 31, 2014. Effective ... end from May 31 to December 31. As a ... today are for the quarter and the seven months ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
Cached News: